sixty-six newly diagnosed patients with acute nonlymphocytic leukemia received either daunorubicin alone or a combination of daunorubicin , cytosine arabinoside , 6-thioguanine , and pyrimethamine for remission-induction therapy .
C0023467
acute nonlymphocytic leukemia
C0011015
daunorubicin